Tumor Necrosis Factor‐Alpha, Interleukin‐6, and Interleukin‐10 Levels are Altered in Preeclampsia: A Systematic Review and Meta‐Analysis
暂无分享,去创建一个
C. Barrett | S. Guild | Qi Chen | L. Chamley | V. Jordan | L. Chamley | S. Lau | L. McCowan
[1] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[2] D. Charnock-Jones,et al. Redefining preeclampsia using placenta-derived biomarkers. , 2013, Hypertension.
[3] K. Wallace,et al. Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia. , 2012, Gender medicine.
[4] B. Tarlatzis,et al. Elevated Serum Levels of Interleukin‐6, Interleukin‐1β and Human Chorionic Gonadotropin in Pre‐eclampsia , 2011, American journal of reproductive immunology.
[5] Jiang-Bo Liu,et al. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. , 2011, Cytokine.
[6] G. Wallukat,et al. Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation. , 2011, International journal of interferon, cytokine and mediator research.
[7] A. Szarka,et al. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[8] A. Szarka,et al. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia , 2011, Reproductive biology and endocrinology : RB&E.
[9] S. Hahn,et al. Placental Microparticles, DNA, and RNA in Preeclampsia , 2011, Hypertension in pregnancy.
[10] G. Wallukat,et al. Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. , 2011, American journal of hypertension.
[11] J. Gjedsted,et al. Longitudinal measurement of cytokines in pre‐eclamptic and normotensive pregnancies , 2011, Acta obstetricia et gynecologica Scandinavica.
[12] G. Wallukat,et al. Angiotensin II Type 1 Receptor Antibodies and Increased Angiotensin II Sensitivity in Pregnant Rats , 2011, Hypertension.
[13] R. Dechend,et al. Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction. , 2011, Gender medicine.
[14] S. Blackwell,et al. Autoantibody-Mediated IL-6–Dependent Endothelin-1 Elevation Underlies Pathogenesis in a Mouse Model of Preeclampsia , 2011, The Journal of Immunology.
[15] J. Granger,et al. Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia. , 2011, Current opinion in pharmacology.
[16] Archana Singh,et al. Role of Endothelin and Inflammatory Cytokines in Pre‐eclampsia – A Pilot North Indian Study , 2011, American journal of reproductive immunology.
[17] J. Granger,et al. Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats. , 2011, American journal of hypertension.
[18] A. Szarka,et al. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array , 2010, BMC Immunology.
[19] K. Lim,et al. Growth Factors , Cytokines , Cell Cycle Molecules Sera from Preeclampsia Patients Elicit Symptoms of Human Disease in Mice and Provide a Basis for an in Vitro Predictive Assay , 2010 .
[20] Maren S Fragala,et al. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research , 2010, Current opinion in clinical nutrition and metabolic care.
[21] M. Tosun,et al. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-α in normal pregnancies and in pregnancies complicated by preeclampsia , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[22] Ioannis P Androulakis,et al. Modeling the influence of circadian rhythms on the acute inflammatory response. , 2010, Journal of theoretical biology.
[23] Qi Chen,et al. The role of autocrine TGFβ1 in endothelial cell activation induced by phagocytosis of necrotic trophoblasts: a possible role in the pathogenesis of pre‐eclampsia , 2010, The Journal of pathology.
[24] Judith E. Cartwright,et al. Pre‐eclampsia: fitting together the placental, immune and cardiovascular pieces , 2010, The Journal of pathology.
[25] P. Julien,et al. Plasma interleukin‐18 (IL‐18) levels are correlated with antioxidant vitamin coenzyme Q10 in preeclampsia , 2010, Acta obstetricia et gynecologica Scandinavica.
[26] M. Lindheimer,et al. Interpreting Abnormal Proteinuria in Pregnancy: The Need for a More Pathophysiological Approach , 2010, Obstetrics and gynecology.
[27] J. Granger,et al. Role of Endothelin in Mediating Soluble fms-Like Tyrosine Kinase 1–Induced Hypertension in Pregnant Rats , 2010, HYPERTENSION.
[28] P. von Dadelszen,et al. Toll‐like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre‐eclampsia , 2010, BJOG : an international journal of obstetrics and gynaecology.
[29] Archana Singh,et al. ORIGINAL ARTICLE: Role of Inflammatory Cytokines and eNOS Gene Polymorphism in Pathophysiology of Pre‐Eclampsia , 2009, American journal of reproductive immunology.
[30] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[31] P. Stone,et al. IL-6, TNFalpha and TGFbeta promote nonapoptotic trophoblast deportation and subsequently causes endothelial cell activation. , 2010, Placenta.
[32] J. Després,et al. Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. , 2009, Metabolism: clinical and experimental.
[33] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[34] H. Ayatollahi,et al. Comparison of maternal serum Tumor Necrosis Factor-alpha (TNF-α) in severe and mild preeclampsia versus normal pregnancy , 2009 .
[35] M. Jovanović,et al. Interleukin-6 stimulates cell migration, invasion and integrin expression in HTR-8/SVneo cell line. , 2009, Placenta.
[36] C. Hubel,et al. The two stage model of preeclampsia: variations on the theme. , 2009, Placenta.
[37] P. Stone,et al. Vitamin C enhances phagocytosis of necrotic trophoblasts by endothelial cells and protects the phagocytosing endothelial cells from activation. , 2009, Placenta.
[38] M. Aral,et al. Association of Maternal Serum CRP, IL-6, TNF-α, Homocysteine, Folic Acid and Vitamin B12 Levels with the Severity of Preeclampsia and Fetal Birth Weight , 2009, Hypertension in pregnancy.
[39] Yan-Qiong Ouyang,et al. Interactions Between Inflammatory and Oxidative Stress in Preeclampsia , 2009, Hypertension in pregnancy.
[40] P. Chedraui,et al. Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia , 2009, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[41] P. Stone,et al. A role for interleukin‐6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: implications for the pathogenesis of pre‐eclampsia , 2009, The Journal of pathology.
[42] I. Adam,et al. Cytokines Profiles in Sudanese Women with Preeclampsia , 2009, Hypertension in pregnancy.
[43] T. Noyan. Serum Mast Cell Tryptase, Eosinophil Cationic Protein, Endothelin-1 and Cytokine Levels in Preeclampsia and Healthy Pregnancy (Preeklampsi ve Sağlikli Gebelikte Serum Mast Hücre Triptaz, Eozinofilik Katyonik Protein, Endotelin-1 ve Sitokin Seviyeleri ) Research Article (Araştirma Makalesi) , 2009 .
[44] M. Emanuelli,et al. Placental Cytokines in the Pathogenesis of Preeclampsia and Hellp Syndrome , 2008 .
[45] E. Norwitz,et al. Fractional Excretion of Tumor Necrosis Factor-&agr; in Women With Severe Preeclampsia , 2008, Obstetrics and gynecology.
[46] Asif Ahmed,et al. Autoantibody From Women With Preeclampsia Induces Soluble Fms-Like Tyrosine Kinase-1 Production via Angiotensin Type 1 Receptor and Calcineurin/Nuclear Factor of Activated T-Cells Signaling , 2008, Hypertension.
[47] B. Huppertz. Placental Origins of Preeclampsia: Challenging the Current Hypothesis , 2008, Hypertension.
[48] I. Sargent,et al. Circulating microparticles in normal pregnancy and pre-eclampsia. , 2008, Placenta.
[49] S. Founds,et al. A Comparison of Circulating TNF-α in Obese and Lean Women with and without Preeclampsia , 2008, Hypertension in pregnancy.
[50] M. Vaid,et al. Inducible nitric oxide synthase (iNOS) gene polymorphism in pre‐eclampsia: A pilot study in North India , 2007, The Australian & New Zealand journal of obstetrics & gynaecology.
[51] M. Vodjgani,et al. Serum cytokines profiles in Iranian patients with preeclampsia. , 2007, Iranian journal of immunology : IJI.
[52] Cenk Fatih Çanakçı,et al. Periodontal disease increases the risk of severe pre-eclampsia among pregnant women. , 2007, Journal of clinical periodontology.
[53] I. Sargent,et al. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles , 2007, The Journal of Immunology.
[54] Alpana Sharma,et al. Leptin, IL‐10 and Inflammatory Markers (TNF‐α, IL‐6 and IL‐8) in Pre‐Eclamptic, Normotensive Pregnant and Healthy Non‐Pregnant Women , 2007, American journal of reproductive immunology.
[55] P. McKenzie,et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. , 2007, Kidney international.
[56] G. Saade,et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. , 2007, American journal of obstetrics and gynecology.
[57] Asif Ahmed,et al. Angiotensin II Induces Soluble fms-Like Tyrosine Kinase-1 Release via Calcineurin Signaling Pathway in Pregnancy , 2007, Circulation research.
[58] J. Després,et al. Postprandial Variations of Plasma Inflammatory Markers in Abdominally Obese Men , 2006, Obesity.
[59] B. Çetinarslan,et al. Association between Circulating Tumor Necrosis Factor-Alpha, Interleukin-6, and Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome. , 2006, Metabolic syndrome and related disorders.
[60] J. Ernerudh,et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. , 2006, Journal of reproductive immunology.
[61] M. Lalu,et al. Preeclampsia: current understanding of the molecular basis of vascular dysfunction , 2006, Expert Reviews in Molecular Medicine.
[62] P. Stone,et al. Phagocytosis of Necrotic but Not Apoptotic Trophoblasts Induces Endothelial Cell Activation , 2006, Hypertension.
[63] E. Bursal,et al. The Serum Interleukin-6 and Tumor Necrosis Factor-α Levels and Their Relationship With Antithrombin-III and von Willebrand Factor In Preeclampsia , 2006 .
[64] L. Magee,et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. , 2006, Placenta.
[65] James M. Roberts,et al. Preeclampsia: recent insights. , 2005, Hypertension.
[66] J. T. Afshari,et al. Determination of Interleukin-6 and Tumor Necrosis Factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia , 2005, BMC pregnancy and childbirth.
[67] U. Singhal,et al. Serum tumor necrosis factor-alpha in pre eclampsia. , 2005, Indian journal of physiology and pharmacology.
[68] L. Khaodhiar,et al. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. , 2004, JPEN. Journal of parenteral and enteral nutrition.
[69] S. Karumanchi,et al. Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. , 2004, Endocrinology.
[70] S. Kōzuma,et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. , 2004, Endocrinology.
[71] L. Cherry,et al. Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia , 2004, Hypertension.
[72] R. Khalil,et al. Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[73] A. Tuzcu,et al. Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women , 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[74] A. Omu,et al. Connection between human leucocyte antigens D region and T helper cytokines in preeclampsia , 2004, Archives of Gynecology and Obstetrics.
[75] S. Aydin,et al. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels , 2003, Acta obstetricia et gynecologica Scandinavica.
[76] P. Steer,et al. Microvascular permeability is related to circulating levels of tumour necrosis factor-alpha in pre-eclampsia. , 2003, Cardiovascular research.
[77] K. Yoneyama,et al. Increased Plasma Adenosine Concentrations and the Severity of Preeclampsia , 2002, Obstetrics and gynecology.
[78] A. Duits,et al. High Serum Interleukin‐8 Levels in Afro‐Caribbean Women with Pre‐eclampsia. Relations with Tumor Necrosis Factor‐α, Duffy Negative Phenotype and Von Willebrand Factor , 2002, American journal of reproductive immunology.
[79] S. Djurovic,et al. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre‐eclampsia , 2002, BJOG : an international journal of obstetrics and gynaecology.
[80] D. Charnock-Jones,et al. Hypoxia-Reoxygenation: A Potent Inducer of Apoptotic Changes in the Human Placenta and Possible Etiological Factor in Preeclampsia , 2002, Circulation research.
[81] B. Özçelik,et al. Predictive value of tumor necrosis factor alpha (TNF-α) in preeclampsia , 2002 .
[82] M. Başbuğ,et al. Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia. , 2002, European journal of obstetrics, gynecology, and reproductive biology.
[83] P. López-Jaramillo,et al. Elevated C‐reactive protein and pro‐inflammatory cytokines in Andean women with pre‐eclampsia , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[84] J. Bartha,et al. The relationships between leptin and inflammatory cytokines in women with pre‐eclampsia , 2001, BJOG : an international journal of obstetrics and gynaecology.
[85] G. Burton,et al. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. , 2001, The American journal of pathology.
[86] Jean-Marie Moutquin,et al. The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.
[87] S. Humphries,et al. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. , 2000, Cytokine.
[88] S. Olusi,et al. Interleukins in preeclampsia. , 2000, Annals of Saudi medicine.
[89] C. Mittermayer,et al. Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1beta cause endothelial activation. , 1999, European journal of obstetrics, gynecology, and reproductive biology.
[90] P. Loizzi,et al. Evaluation of Nonspecific Immunity and Plasma Levels of Interferon-γ, Interleukin-6 and Tumor Necrosis Factor-α in Preeclampsia , 1999 .
[91] A. Omu,et al. Differential levels of T helper cytokines in preeclampsia: pregnancy, labor and puerperium. , 1999, Acta obstetricia et gynecologica Scandinavica.
[92] L C Harrison,et al. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. , 1998, Cytokine.
[93] A. Greenberg,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .
[94] R. Grimble,et al. Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids. , 1998, Zeitschrift fur Ernahrungswissenschaft.
[95] J S Yudkin,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .
[96] C. Mantzoros,et al. Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans , 1997 .
[97] S. Kōzuma,et al. Evidence for an Elevation in Serum Interleukin‐2 and Tumor Necrosis Factor‐α Levels Before the Clinical Manifestations of Preeclampsia , 1997, American journal of reproductive immunology.
[98] A. Peaceman,et al. Soluble tumor necrosis factor receptors and interleukin‐6 levels in patients with severe preeclampsia , 1996, Obstetrics and gynecology.
[99] S. Bulun,et al. Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells , 1996, Molecular and Cellular Endocrinology.
[100] R. Simsolo,et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.
[101] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[102] D. Kwiatkowski,et al. Interleukin‐6, turnour necrosis factor and soluble turnour necrosis factor receptors in women with pre‐eclampsia , 1995 .
[103] D. Kwiatkowski,et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. , 1995, British journal of obstetrics and gynaecology.
[104] I. Greer,et al. Increased concentrations of dytokines interleukin and interleukin‐1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction? , 1994, Obstetrics and gynecology.
[105] Jean Golding,et al. Geographic variation in incidence of hypertension in pregnancy , 1988 .
[106] J. Meer,et al. Interleukin-1 beta in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods. , 1988, Lymphokine research.
[107] R. Cotran,et al. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.